Publication | Closed Access
INTRAVITREAL RANIBIZUMAB FOR MYOPIC CHOROIDAL NEOVASCULARIZATION
76
Citations
17
References
2010
Year
One-year results of intravitreal ranibizumab for myopic choroidal neovascularization are very promising. Additional prospective studies are necessary to better determine long-term efficacy and safety.
| Year | Citations | |
|---|---|---|
Page 1
Page 1